Meta-analysis and review of dopamine agonists in acute episodes of mood disorder: Efficacy and safety

DOI Web Site Web Site 被引用文献1件
  • Bruno Romeo
    Department of Psychiatry and Addictology, Paul Brousse Hospital, Villejuif, France
  • Lisa Blecha
    Department of Psychiatry and Addictology, Paul Brousse Hospital, Villejuif, France
  • Katia Locatelli
    Department of Psychiatry and Addictology, Paul Brousse Hospital, Villejuif, France
  • Amine Benyamina
    Department of Psychiatry and Addictology, Paul Brousse Hospital, Villejuif, France
  • Catherine Martelli
    Department of Psychiatry and Addictology, Paul Brousse Hospital, Villejuif, France

説明

<jats:p> The objective of this meta-analysis is to assess the efficacy and safety of partial and complete dopamine agonists in the treatment of acute mood disorder episodes. Randomized, double-blind and placebo-controlled trials of dopamine agonists in the treatment of acute mood disorder episodes were identified in the MEDLINE and PsycINFO databases and included in the meta-analysis. In monotherapy of mania, improved remission rates were found for cariprazine (odds ratio (OR): 2.08, P < 0.01) and for high-dose aripiprazole (OR: 3.00; P = 0.05), but not for low-dose aripiprazole. In bipolar depression, no improvement of remission and response rates was found for aripiprazole in monotherapy, whereas improved response rate (OR: 10.27, P < 0.01) was found for pramipexole only as an add-on to another mood stabilizer. In major depressive disorder, relatively similar improvements of remission rates were found for high-dose (OR: 1.96, p < 0.01) and low-dose aripiprazole (OR: 1.68, P = 0.01), as well as brexpiprazole (OR: 1.52, P = 0.05) as an add-on to antidepressant medication. Our meta-analysis shows that partial dopamine agonists at high doses are effective in treating acute mania. In major depressive disorder, which is resistant to classical antidepressants, low doses of partial dopamine agonists as adjunct therapy may represent a relatively safe and effective alternative. </jats:p>

収録刊行物

被引用文献 (1)*注記

もっと見る

問題の指摘

ページトップへ